These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31148158)

  • 1. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
    Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
    Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
    Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR;
    Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment.
    Frei-Jones MJ; Baxter AL; Rogers ZR; Buchanan GR
    J Pediatr; 2008 Feb; 152(2):281-5. PubMed ID: 18206703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD; McCavit TL
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P; Hafner JW; Martinovich Z; Artz N
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
    Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM
    Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease.
    Lyon M; Sturgis L; Lottenberg R; Gibson ME; Eck J; Kutlar A; Gibson RW
    Ann Emerg Med; 2020 Sep; 76(3S):S12-S20. PubMed ID: 32928457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
    Ibemere SO; Dubbs SB; Barnhart HX; Brown JL; Freiermuth CE; Kavanagh P; Paice JA; Strouse JJ; Wilkerson RG; Tanabe P;
    Contemp Clin Trials; 2021 Feb; 101():106252. PubMed ID: 33348066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease.
    Beyer JE
    J Pain Symptom Manage; 2000 Jan; 19(1):63-72. PubMed ID: 10687328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of analgesic use in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
    Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
    J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study.
    Donado C; Harris EM; Heeney MM; Solodiuk JC; Greco CD; Archer NM
    J Pain Symptom Manage; 2023 May; 65(5):e409-e415. PubMed ID: 36641004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
    Morris CR; Brown LAS; Reynolds M; Dampier CD; Lane PA; Watt A; Kumari P; Harris F; Manoranjithan S; Mendis RD; Figueroa J; Shiva S
    Blood; 2020 Sep; 136(12):1402-1406. PubMed ID: 32384147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.